Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Antibiotic Therapy for Hospital-Acquired Infections in ICU Patients (ANTHICUS)
This study has been completed.
Sponsored by: AstraZeneca
Information provided by: AstraZeneca
ClinicalTrials.gov Identifier: NCT00543894
  Purpose

Antibiotic Therapy for Hospital-Acquired Infections in ICU Patients. A prospective, observational, multicenter study (ANTHICUS).


Condition
Infection in ICU

MedlinePlus related topics: Antibiotics
U.S. FDA Resources
Study Type: Observational
Study Design: Prospective
Official Title: Antibiotic Therapy for Hospital-Acquired Infections in ICU Patients. A Prospective, Observational, Multicenter Study (ANTHICUS)

Further study details as provided by AstraZeneca:

Secondary Outcome Measures:
  • the frequency of appropriate antibiotic therapy (defined as the use of antibiotic(s) with "in vitro" efficacy against the identified pathogens responsible for the infection)
  • the frequency of "the strategy of de-escalation" according to the culture results

Enrollment: 500
Study Start Date: February 2006
  Eligibility

Criteria

Inclusion Criteria:

  • Patients with hospital-acquired infections and hospitalised in the ICU at one moment of their hospital stay

  • Hospital-acquired infections accounting for eligibility are:

    • nosocomial pneumonia (including ventilator-associated pneumonia)
    • bacteremia
    • intra-abdominal infections
    • urosepsis
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00543894

Sponsors and Collaborators
AstraZeneca
Investigators
Principal Investigator: Pr Vogelaers UZ Gents
  More Information

Study ID Numbers: SRP-HB-MER-2005/1
Study First Received: October 11, 2007
Last Updated: August 11, 2008
ClinicalTrials.gov Identifier: NCT00543894  
Health Authority: Belgium: Federal Agency for Medicinal Products and Health Products

Keywords provided by AstraZeneca:
Antibiotic, ICU, hospital acquired infection.

Study placed in the following topic categories:
Cross Infection

Additional relevant MeSH terms:
Communicable Diseases
Infection

ClinicalTrials.gov processed this record on January 15, 2009



U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services